RU2006146051A - Новые соединения, фармацевтические композиции на их основе и способы применения - Google Patents

Новые соединения, фармацевтические композиции на их основе и способы применения Download PDF

Info

Publication number
RU2006146051A
RU2006146051A RU2006146051/04A RU2006146051A RU2006146051A RU 2006146051 A RU2006146051 A RU 2006146051A RU 2006146051/04 A RU2006146051/04 A RU 2006146051/04A RU 2006146051 A RU2006146051 A RU 2006146051A RU 2006146051 A RU2006146051 A RU 2006146051A
Authority
RU
Russia
Prior art keywords
compound
compound according
pharmaceutical composition
alkylaryl
arylalkyl
Prior art date
Application number
RU2006146051/04A
Other languages
English (en)
Russian (ru)
Inventor
Джилл М. МАКФЭДДЕН (US)
Джилл М. Макфэдден
Крэйг А. ТАУНСЕНД (US)
Крэйг А. Таунсенд
Сьюзан М. МЕДХАЛЧИ (US)
Сьюзан М. МЕДХАЛЧИ
Original Assignee
Фасджен
ФАСДЖЕН, Эл Эл Си
Эл Эл Си (US)
Дзе Джонс Хопкинс Юниверсити
Дзе Джонс Хопкинс Юниверсити (Us)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фасджен, ФАСДЖЕН, Эл Эл Си, Эл Эл Си (US), Дзе Джонс Хопкинс Юниверсити, Дзе Джонс Хопкинс Юниверсити (Us) filed Critical Фасджен
Publication of RU2006146051A publication Critical patent/RU2006146051A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/06—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
RU2006146051/04A 2004-05-26 2005-05-25 Новые соединения, фармацевтические композиции на их основе и способы применения RU2006146051A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57463904P 2004-05-26 2004-05-26
US60/574,639 2004-05-26

Publications (1)

Publication Number Publication Date
RU2006146051A true RU2006146051A (ru) 2008-07-10

Family

ID=35463277

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006146051/04A RU2006146051A (ru) 2004-05-26 2005-05-25 Новые соединения, фармацевтические композиции на их основе и способы применения

Country Status (13)

Country Link
US (1) US20090005435A1 (cg-RX-API-DMAC7.html)
EP (1) EP1758577A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008500363A (cg-RX-API-DMAC7.html)
KR (1) KR20070095754A (cg-RX-API-DMAC7.html)
CN (1) CN101022792A (cg-RX-API-DMAC7.html)
AU (1) AU2005249437A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510397A (cg-RX-API-DMAC7.html)
CA (1) CA2568639A1 (cg-RX-API-DMAC7.html)
IL (1) IL179530A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013687A (cg-RX-API-DMAC7.html)
RU (1) RU2006146051A (cg-RX-API-DMAC7.html)
WO (1) WO2005117590A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200700024B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007014248A2 (en) * 2005-07-26 2007-02-01 Johns Hopkins University Method of reducing food intake
AU2007300627B2 (en) * 2006-09-22 2012-02-16 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
KR101640263B1 (ko) * 2007-10-05 2016-07-15 젠자임 코포레이션 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법
WO2010118324A2 (en) 2009-04-09 2010-10-14 Nuclea Biotechnologies, LLC Antibodies against fatty acid synthase
WO2014039769A1 (en) * 2012-09-07 2014-03-13 Janssen Pharmaceutica Nv Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
CA2968288A1 (en) 2014-11-20 2016-05-26 Vib Vzw Means and methods for treatment of early-onset parkinson's disease
CN114980740A (zh) 2020-01-23 2022-08-30 巴斯夫欧洲公司 用于农业化学配制剂的新型添加剂
CN116507203B (zh) 2020-10-27 2026-08-07 巴斯夫欧洲公司 农药微乳剂组合物
CA3207197A1 (en) 2021-02-05 2022-08-11 Murat Mertoglu Liquid herbicidal compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3427847A1 (de) * 1983-12-09 1985-06-13 Bayer Ag, 5090 Leverkusen Thiolan-2,4-dion-3-carboxamide
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
MXPA04007556A (es) * 2002-02-08 2005-12-05 Univ Johns Hopkins Med Estimulacion de cpt-1 como medio para reducir peso.
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same

Also Published As

Publication number Publication date
WO2005117590A3 (en) 2006-07-27
WO2005117590A2 (en) 2005-12-15
ZA200700024B (en) 2008-06-25
JP2008500363A (ja) 2008-01-10
AU2005249437A1 (en) 2005-12-15
EP1758577A2 (en) 2007-03-07
BRPI0510397A (pt) 2007-11-13
US20090005435A1 (en) 2009-01-01
EP1758577A4 (en) 2010-05-05
CA2568639A1 (en) 2005-12-15
IL179530A0 (en) 2007-05-15
MXPA06013687A (es) 2007-10-18
CN101022792A (zh) 2007-08-22
KR20070095754A (ko) 2007-10-01

Similar Documents

Publication Publication Date Title
RU2221798C2 (ru) Имидазонафтиридины, фармацевтическая композиция на их основе, способ стимуляции биосинтеза цитокина и промежуточные вещества
RU2008123839A (ru) Соединение оксазола и фармацевтическая композиция
RU2403251C2 (ru) Производные 2, 4-ди(гетеро)ариламинопиримидина в качестве ингибиторов zap-70
RU2327701C2 (ru) Нуклеозидные производные и фармацевтическая композиция, обладающая антивирусной активностью в отношении hcv
RU2006101987A (ru) Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции
NO20013367D0 (no) Colchinolderivater som vaskul¶rskadende midler
RU2342367C2 (ru) Ненуклеозидные ингибиторы i обратной транскриптазы, предназначенные для лечения заболеваний, опосредованных вич
RU2005108046A (ru) 1, 2, 3-триазольные производные, обладающие бактерицидной (например, фунгицидной)активностью
RU2000132188A (ru) Производные эпотилонов, их синтез и применение
RU2013152132A (ru) Борсодержащие малые молекулы в качестве противовоспалительных средств
RU92016218A (ru) Производные триазолопиримидина, их применение, способ их получения, фунгицидная композиция, способ борьбы с грибками
RU2010145529A (ru) Композиции гидрофобных производных таксана и их применение
EA200401614A1 (ru) O-замещённые гидроксиарильные производные
RU2003116059A (ru) Арилэфирзамещенные имидазохинолины
RU2002107975A (ru) Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения
CY1111980T1 (el) Παραγωγα του αμιδιου τα οποια φερουν ενα υποκαταστατο του κυκλοπροπυλαμινοκαρβονυλιου και χρησιμευουν ως αναστολεις κυτταροκινης
AR054475A1 (es) Fenilfosfatos sustituidos como profarmacos mutuos de esteroides y (beta)-agonistas para el tratamiento de la inflamacion pulmonar y la broncoconstriccion
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
RU2220140C2 (ru) Производное циклических амидов, фармацевтическая композиция и лекарственное средство, его содержащее, и способ лечения аллергического заболевания
RU2003134629A (ru) Соединения цефема
RU2004133555A (ru) Тоник для роста волос
JP2008500363A5 (cg-RX-API-DMAC7.html)
RU2008112884A (ru) Агент для снижения инсулинорезистентности
JPS5716841A (en) Novel compound,manufacture,bactericidal composition and use
RU2011129771A (ru) Противораковые соединения

Legal Events

Date Code Title Description
FA94 Acknowledgement of application withdrawn (non-payment of fees)

Effective date: 20110516